- Reuters•19 days ago
Buyout groups Bain Capital and Cinven won an auction for German drugmaker Stada on Monday after a surprisingly large increase on a previous bid valued the company at about 5.3 billion euros ($5.6 billion). The private equity consortium is offering 65.28 euros per share and a dividend of 0.72 euro per Stada share, the company said in a statement on Monday, earning the backing of Stada management. Bain and Cinven had been vying with a rival consortium comprising Advent and Permira for control of generic drugmaker Stada.
- The Wall Street Journal•19 days ago
German drugmaker Stada Arzneimittel said it would support a sweetened joint takeover offer by private-equity firms Bain Capital and Cinven worth $4.35 billion.
- The Wall Street Journal•24 days ago
Activist investing is on the rise in the old world, but local rules demand a local game plan.
SAZ.DE : Summary for STADA ARZNEIMITT. NA O.N. - Yahoo Finance
STADA Arzneimittel Aktiengesellschaft (SAZ.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
|Bid||0.00 x 5000|
|Ask||0.00 x 28500|
|Day's Range||64.70 - 65.16|
|52 Week Range||37.03 - 65.16|
|PE Ratio (TTM)||47.12|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|